Full text
Acta Neurochirurgica (2022) 164:2021–2034 Vol.:(0123456789) 1 3 https://doi.org/10.1007/s00701-022-05162-5 ORIGINAL ARTICLE - BRAIN TUMORS Assessment ofneuropsychological function inbrain tumor treatment: acomparison oftraditional neuropsychological assessment withapp‑based cognitive screening RafaelRomero‑Garcia1,2 · MalloryOwen1· AlexaMcDonald3· EmmaWoodberry3· MoatazAssem4· PedroCoelho5· RobC.Morris6· StephenJ.Price6· TomSantarius6,7· JohnSuckling1,8,9· TomManly9· YaaraErez4,10· MichaelG.Hart1 Received: 9 August 2021 / Accepted: 16 February 2022 © The Author(s) 2022 Abstract Background Gliomas are typically considered to cause relatively few neurological impairments. However, cognitive difficulties can arise, for example during treatment, with potential detrimental effects on quality of life. Accurate, reproducible, and accessible cognitive assessment is therefore vital in understanding the effects of both tumor and treatments. Our aim is to compare traditional neuropsychological assessment with an app-based cognitive screening tool in patients with glioma before and after surgical resection. Our hypotheses were that cognitive impairments would be apparent, even in a young and high functioning cohort, and that app-based cognitive screening would complement traditional neuropsychological assessment. Methods Seventeen patients with diffuse gliomas completed a traditional neuropsychological assessment and an app-based touchscreen tablet assessment preand post-operatively. The app assessment was also conducted at 3and 12-month followup. Impairment rates, mean performance, and preand post-operative changes were compared using standardized Z-scores. Results Approximately 2–3h of traditional assessment indicated an average of 2.88 cognitive impairments per patient, while the 30-min screen indicated 1.18. As might be expected, traditional assessment using multiple items across the difficulty range proved more sensitive than brief screening measures in areas such as memory and attention. However, the capacity of the screening app to capture reaction times enhanced its sensitivity, relative to traditional assessment, in the area of non-verbal function. Where there was overlap between the two assessments, for example digit span tasks, the results were broadly equivalent. Conclusions Cognitive impairments were common in this sample and app-based screening complemented traditional neuropsychological assessment. Implications for clinical assessment and follow-up are discussed. Keywords Glioma· Neuropsychology· Neuropsychiatry· Neurosurgery· Cognitive function Introduction Patients with diffuse glioma can develop impairments in multiple cognitive domains before or after surgery that can have a profound effect on function and quality of life [9, 25]. The type of impairment can be influenced by tumor morphology, extent of resection and post-surgical treatment, tumor recurrence, age, and concurrent psychological distress [1, 8, 13, 15, 16, 19, 30, 34, 35]. However, in any given case, it is difficult to make precise predictions about cognitive outcome due to, e.g., individual differences and long-ranging effects of diffuse gliomas on networks throughout the brain [11, 12, 27, 31]. Assessment of cognitive function is therefore vital in informing management and in monitoring the long-term effects of tumors and interventions. Despite recognition of this importance, several issues remain with current diffuse glioma neurocognitive testing. In a traditional cognitive assessment, a neuropsychologist works through a range of in-depth assessments with the patient, Rafael Romero-Garcia and Mallory Owen contributed equally to this work. This article is part of the Topical Collection on Brain Tumors * Rafael Romero-Garcia r[email protected] Extended author information available on the last page of the article Published online: 1 March 2022 /
Acta Neurochirurgica (2022) 164:2021–2034 1 3 writing down the responses then manually scoring and writing a report. The range of tests reflects the fractionation of the cognitive system, that is distinct functions that can be selectively impaired. For example, in the area of memory, a neuropsychologist may apply different tests of verbal and non-verbal memory, recognition memory vs. recall, autobiographical memory, prospective memory, working memory, and so on. These tests typically present many items, graded in difficulty, such that the tests are sensitive to individual differences in the general population as well as simply detecting “impairment.” This approach has great strengths but also important limitations. In-depth assessment of an individual can take several hours, in addition to scoring and report writing time. A long assessment may be highly sensitive in the general population but be overly influenced by fatigue, pain, or other factors in clinical groups [30]. There is such a wide range of specialized tests available that there may be little overlap between those used in one center and another, making comparison of outcomes complex [22, 26, 28]. Many tests have strong or unknown practice effects, limiting their use for repeated assessments. Computerized cognitive assessments offer potential advantages including highly standardized administration, the capacity to measure reaction times with millisecond precision, and instant scoring/reporting. In this way, indications of possible impairment in language, memory, orientation, attention, numerical cognition, spatial bias, and ability to imitate gestures can be derived in around 10min, helping to inform management in settings where patients may be intolerant of longer assessments (e.g., acute stroke). The advent of the touchscreen tablet added portability and suitability for bedside use, greater hygiene, a more intuitive means of interaction, and further reduced costs. OCS-BRIDGE is a recently developed tablet app that is a hybrid between very brief screening and more in-depth assessment (https:// ocsbridge. com/) [6, 18]. To date, there are no reports of the use of app-based cognitive assessment in diffuse glioma. Here 17 patients were given a traditional neuropsychological assessment and OCSBRIDGE assessment before and after surgery. In addition, OCS-BRIDGE was re-administered at 3and 12-month follow-up. Our interest was whether OCS-BRIDGE offered advantages in terms of ease of administration and efficiency of repeated testing in longitudinal studies, whether its results accorded well with traditional in-depth assessment, and whether aspects of the two approaches may be complementary. Materials andmethods Participants This study is a single-center prospective cohort design approved by the Cambridge Central Research Ethics Committee (protocol number 16/EE/0151). All procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. All patients gave written informed consent. Patients deemed to have typical appearances of a diffuse glioma were identified at adult neuro-oncology multidisciplinary team (MDT) meetings at Addenbrooke’s Hospital (Cambridge, UK), and a consultant neurosurgeon directly involved in the study identified potential patients based on the outcome of the MDT discussion. Patients (n = 17) were recruited between 2017 and 2019 and followed up until 2020. Inclusion criteria included the following: (i) participant is willing and able to give informed consent for participation in the study, (ii) imaging is evaluated by the MDT and judged to have typical appearances of a diffuse glioma, (iii) stealth MRI is obtained (routine neuronavigation MRI scan performed prior to surgery), (iv) World Health Organization (WHO) performance status 0 or 1, (v) age between 18 and 80years, (vi) tumor located in or near eloquent areas of the brain thought to be important for speech and executive functions, and (vii) patient undergoing awake surgical resection of a diffuse glioma. This last inclusion criterion was adopted to collect additional intraoperative electrocorticography data that will be reported separately [10]. Participants were excluded if any of the following applied: (i) concomitant anti-cancer therapy, (ii) concomitant treatment with steroids, (iii) history of previous malignancy (except for adequately treated basal and squamous cell carcinoma or carcinoma insitu of the skin) within 5years, and (iv) previous severe head injury. See Table1 for demographic and clinical characteristics. Cognitive assessment Cognitive assessment was carried out using two distinct methods at various time points before and after surgery. Traditional neuropsychological assessment The neuropsychological battery comprised 26 independent measures of cognitive function across eight domains: verbal memory, nonverbal memory, verbal skills, nonverbal skills, attention, executive function, and mood disturbance using a variety of previously validated tests [20, 24, 33]. The battery included elements of both the Weschler Adult Intelligence Scale IV, which has previously been used to assess cognitive functioning in glioma patients [37], and the Brain Injury Rehabilitation Trust Memory and Information Processing Battery, which was specifically designed for patients with neurological injuries [5]. Testing took approximately 2–3h to complete and was administered by a registered neuropsychologist in a 2022
Acta Neurochirurgica (2022) 164:2021–2034 1 3 clinical setting. A full list of the tests included on both the OCS-BRIDGE and the neuropsychological assessments can be found in TableS1. OCS‑BRIDGE assessment This novel app-based screening tool, administered via touchscreen tablet, consists of 3 parts. The first part is based on the Oxford Cognitive Screen (OCS) and consists of a brief screening of language, orientation, attention, perception, memory, praxis, and numeracy skills, based on a paperand-pencil measure extensively validated in stroke [6, 18]. The second part of OCS-BRIDGE provides more sensitive measures, adapted from well-established test paradigms, for patients able to tolerate a slightly longer assessment of 25–40min. It includes measures of reaction time, working memory, and visual perception. Screening included 6 memory tasks: free verbal memory, overall verbal memory, episodic memory, orientation (spatial memory), forward and backward digit span (verbal short term and working memory) [32, 36]. Because performance benefits from previous exposure to the tasks (practice effect) tend to be less marked on such measures, they also lend themselves to repeat assessment in longitudinal follow-up. The final part of OCS-BRIDGE consists of the widely used mood measures PHQ-9 and GAD-7 [14, 29]. OCS-BRIDGE was administered pre-operatively, post-operatively prior to discharge, as well as at 3-month and 12-month follow-up, and took between 20 and 35min to complete. Cognitive impairment quantification An impairment in either assessment technique was defined by convention as performance two standard deviations below the mean of a reference control population on any particular test or test component. OCS-BRIDGE offers a second category of “possibly impaired” for scores that fall approximately between the 5th and the 10th percentile. The total impairments in each domain were defined as the number of individual tests within that domain on which a participant demonstrated an impairment. Individual domains from the neuropsychological battery and the OCS-BRIDGE assessment were combined into four generalized functional domains for the purposes of direct comparison: attention, memory, verbal skills, and nonverbal skills (TableS2). The neuropsychological battery also included two tests of executive function that provided four independent measures, as well as two assessments of mood. These were included in the analysis as their own domains. Neuropsychological and OCS-BRIDGE values were z-scored by subtracting the mean and dividing by the standard deviation derived from normative healthy participants. Normative data for neuropsychological assessments were obtained from participants aged 16 to 89. OCS-BRIDGE reference scores were derived from 268 healthy controls (mean age, 51.44, SD age 19.86). These samples were representative of the general distribution in terms of age, gender, and educational level. Neurological/health conditions that were likely to impact on scores (e.g., stroke, epilepsy, medications, uncorrected hearing loss) were an exclusion criterion. Table 1 Demographic information. SFG, superior frontal gyrus; MFG, middle frontal gyrus; IFG, inferior frontal gyrus; ITG, inferior temporal gyrus; MTG, middle temporal gyrus; SMA, supplementary motor area. Ages have been rounded to off for anonymity Patient Age Gender Handedness Presentation Hemisphere Location Tumor grade/pathology 1 40 Female Left Seizures Left Frontal Grade II oligodendroglioma 2 30 Male Right Seizures Right Insula Grade II astrocytoma 3 30 Male Right Seizures Left Temporal/insula Grade IV glioblastoma 4 50 Female Right Incidental Right Insula Grade II oligodendroglioma 5 60 Female Right Recurrence Left Frontal/SFG/frontal pole Grade II oligodendroglioma 6 20 Female Left Seizures Right Frontal/IFG Grade I ganglioglioma 7 30 Male Right Seizures Right Frontal/SFG and MFG Grade III astrocytoma 8 30 Male Right Seizures Right Frontal/MFG Grade III astrocytoma 9 50 Male Left Seizures Left Temporal/ITG Grade IV glioblastoma 10 40 Female Right Seizures Right Frontal/MFG Grade II oligodendroglioma 11 30 Male Right Seizures Left Frontal/SFG/frontal pole Grade II astrocytoma 12 30 Female Right Headaches Left Temporal/MTG Grade III astrocytoma 13 30 Female Right Seizures Left Superior temporal gyrus Grade I ganglioglioma 14 60 Female Right Seizures Left Superior temporal gyrus Grade II astrocytoma 15 30 Male Right Seizures Left Superior temporal gyrus Grade III astrocytoma 16 30 Male Right Seizures Left SFG/SMA and pre-central Grade IV glioblastoma 17 30 Male Right Seizures Left Inferior frontal Grade III astrocytoma 2023
Acta Neurochirurgica (2022) 164:2021–2034 1 3 Further details on the normative data can be found in each individual test manual. Statistical analysis All statistical analyses were carried out in R (R Core Team, 2014) and Matlab R2021b. The Z-score of a given domain was calculated as the median Z-score of all the items belonging to that domain. We additionally calculated the ratio of cognitive deficits for each patient as the number of tasks showing a deficit (performance below threshold) divided by the total number of tasks. The t-value and P-value were calculated using an unpaired t-test between assessments across patients. The number of tasks that contributed to each domain differed and full details are available in TableS1. Although the number of participants in the current study is low for formal analysis, for illustration, unsupervised clustering analysis was carried out using the K-means algorithm. Individual tests that did not show any variation in score between participants were omitted from the clustering analysis, excluding 14/39 OCS-BRIDGE, and 1/28 neuropsychological measures. Clustering was performed on values that had been centered to a mean value of 0 with a standard deviation of 1. K-means clustering was done with a k value of 4 based on the within-groups sum of squares. Analysis was performed using the k-means function in R version 3.6.1. Clusters were visualized by performing a principal components analysis using the fviz function in the factoextra package and plotting the individual cognitive tests against the first and second principal components. Results Demographics anddata completeness No significant difference was found in total impairments reported preoperatively between rightand left-handed participants (t = 0.547, P = 0.6183), male and female (t = 01.175, P = 0.258), or rightand left-sided tumors (t = 0.845, P = 0.411). The correlation between age and impairment frequency did not reach statistical significance (r = − 0.22, P = 0.39). All participants completed pre-operative traditional neuropsychology and OCS-BRIDGE assessments. Fourteen participants completed traditional neuropsychology between 2 and 5weeks after surgery, and eight completed postoperative OCS-BRIDGE assessments within 72h. Eleven participants completed an OCS-BRIDGE assessment at 3-month follow-up and at 12-month follow-up. Sixteen of seventeen participants had at least one OCS-BRIDGE assessment after surgery (see TableS3). Neuropsychiatric function In this sample, anxiety was at a relatively low level with just 3/17 participants pre-operatively scoring within the mild range on the Beck Anxiety Index (BAI) and 2/17 in the moderate range. There was no association between mood status and frequency of cognitive impairment in this sample (BAI status–total cognitive impairments t = 1.2789, P = 0.22; BDI status–total cognitive impairments t = 0.87, P = 0.4). Traditional neuropsychological assessment On traditional neuropsychological assessment, pre-surgically, 79% (14/17) of participants had an impairment in at least one domain, with a mean of 2.88 (SD = 2.47) impairments per participant. Three participants performed above cutoff in all domains. Impairments were observed in the domains of attention (7), verbal memory (7), verbal skills (6), nonverbal memory (4), and executive function (3). Of the 26 cognitive measures in the battery, 16 detected at least one impaired level of performance among the participants while 10 returned no impaired scores for any participant. After surgery, all but one participant had an impairment in at least one domain, with a mean of 4.50 impairments per participant (SD = 3.40). Compared with testing before surgery, the total number of cognitive impairments apparently reduced in 43% (6/14) participants, remained unchanged in 7% (1/14), and increased by 50% (7/14) (Fig.1). Of the 7 participants with more impairments, the average increase was 4.14 (SD 3.18). Three domains (verbal memory, nonverbal memory, and verbal skills) demonstrated an increase in impairments after surgery, two domains (nonverbal skills and attention) remained unchanged, and one (executive function) improved. No participants demonstrated an impairment in nonverbal skills at any point. OCS‑BRIDGE testing As expected, OCS-bridge assessment required considerably less administration time (mean = 30.5min, SD = 7.4) than traditional assessment (2–3h). Before surgery, 59% (10/17) of participants had an impairment in at least one OCS-BRIDGE domain, with a mean of 0.94 impairments (SD = 1.08) per participant. Impairments before surgery occurred in the domains of numerical cognition (4), perception (3), attention (3), language (1), praxis (1), and verbal working memory (1). No participants showed an impairment in memory or prospective memory before surgery. Of the 39 individual cognitive tests included in the OCS-BRIDGE battery, 26 (66%) detected at least 1 impaired performance 2024
Acta Neurochirurgica (2022) 164:2021–2034 1 3 while performance on the remaining 13 was uniformly within the normal range. OCS‑BRIDGE longitudinal changes OCS-BRIDGE’s relative brevity and ease of administration lent itself to longitudinal assessment as part of follow-up clinics. The variation of postoperative impairments detected is shown in Fig.2. The greatest number was seen in attention and non-verbal skills. Of the 16 participants who had at least one post-operative assessment, 44% (7/16) had a reduced number of impairments by their last assessment, 25% (4/16) had the same, and 31% (5/16) showed an increase. Four participants who had multiple follow-ups showed a pattern of increased impairments on either post-operative or 3-month testing which resolved by their last follow-up date. Three of these four participants showed a transient increase of at least one impairment in perception, and two showed a transient increase in memory impairments. Ten of the sixteen participants who had at least one follow-up OCS-BRIDGE assessment ended the study with no impairment on formal testing. Comparison ofOCS‑BRIDGE withtraditional neuropsychological testing As discussed, a proportion of the OCS-BRIDGE tests are extremely brief screening measures—the authors, therefore, applied a conservative strategy to avoid a high, and hence uninformative, level of false positives. It would therefore be predicted that OCS-BRIDGE would be less sensitive to impairments than in-depth traditional neuropsychological assessments. Figure3A shows the total number of preoperative impairments detected in different domains using the two methods (Fig.3A). The tests in the two batteries vary quite widely but one area of commonality is in the forward and backward digit span tests. As shown in Fig.3B, the tests returned similar findings with no statistically significant differences on the forward (traditional mean = 6.29, SD = 1.40 vs. OCS-BRIDGE mean 6.76, SD = 0.90; t = − 1.367, P = 0.1905) or backward tests (traditional mean = 4.47, SD = 1.28 vs. OCS-BRIDGE mean = 4.82, SD = 1.55; t = − 0.972, P = 0.3456). Overall, traditional neuropsychological tests detected 44 preoperative impairments among the 17 participants in the four combined domains of attention, memory, verbal skills, and non-verbal skills. OCS-BRIDGE detected 13 impairments and 28 possible impairments pre-operatively (Fig.3C). The average ratio of detected deficits was significantly higher for the neuropsychological assessments than for OCS-BRIDGE in the attention (preoperative, t = 3.35, P = 0.002; postoperative, t = 2.64, P = 0.016) and memory (preoperative, t = 3.24, P = 0.003; postoperative, t = 1.79, P = 0.088) domains. On the contrary, OCS-BRIDGE revealed a higher ratio of non-verbal skills deficits than Fig. 1 Change in the total number of deficits for each patient between preand postoperative traditional neuropsychology testing 2025
Acta Neurochirurgica (2022) 164:2021–2034 1 3 neuropsychological assessments (preoperative, t = − 3.11, P = 0.004; postoperative, t = − 3.16, P = 0.005) (see Table2 for the average ratio of deficits per assessment and TableS4 for the total number of deficits). Z-scores were calculated from both the neuropsychological testing and the OCS-BRIDGE data for each individual test (Table3). The only significant differences before and after surgery at item level (OCS-BRIDGE extinction.totalCorrect and boat.lineHeight; Neuropsychology AIMPB Story Immediate Recall and BMIPB Word list A6) did not survive correction for multiple comparisons. Item Z-scores were averaged over each domain, revealing a variety of shape distributions with a predominance of normal (neuropsychology verbal skills) and negatively skewed (memory, non-verbal skills, executive function) forms (Fig.S1). No outliers were observed that may have overtly influenced statistical testing. Total and memory preoperative Z-score for neuropsychological testing were weakly correlated with OCS-BRIDGE Z-score across patients but significance did not survive multiple correction (Total, R = 0.49, Puncorrected = 0.045; Attention, R = 0.27, Puncorrected = 0.29; Memory, R = 0.50, Puncorrected = 0.041; Non-verbal skills, R = 0.06, Puncorrected = 0.82; Fig.4). At the group level, only attention preoperative scores were significantly different between neuropsychology and OCS-BRIDGE (Pcorrected = 0.04. Table4). To explore this further, unsupervised clustering was carried out to assess whether individual tests clustered into groups that were different from the original domains (Fig.5). Clusters were named for their dominant test type. Cluster 1 included 10 tests, predominantly memory tests from the traditional battery, and included all but one test from AMIPB and BMIPB. Cluster 2 included 10 tests, 8 from the traditional battery and 2 from OCS-BRIDGE, and was mostly composed of Attention and Verbal Skills tests. Cluster 3 included only 4 tests, 3 of which were from the SALT attention task within the OCS-BRIDGE battery. Finally, cluster 4 was the largest cluster, with 29 of the total tests, and included all but one of the tests of non-verbal skills, as well as 10 out of 14 of the OCS-BRIDGE attention tests. Tasks which included several individual tests, such as the OCS-BRIDGE Hearts and SALT tasks, clustered together, in cluster 4 and cluster 3 respectively. The Beck Depression Inventory fell into cluster 1, while the Beck Anxiety Inventory fell into cluster 4. Discussion Diffuse glioma can cause cognitive impairments and identifying these is important in informing patients and families, in improving management, and in evaluating outcomes. Traditional neuropsychological testing is resource-intensive, making it difficult to perform at multiple time points during the patient journey [30]. Tablet-based assessments tools such Fig. 2 Number of cognitive deficits over time based on OCS-BRIDGE assessment preoperatively, postoperatively and at 3and 12-month follow-ups 2026
Acta Neurochirurgica (2022) 164:2021–2034 1 3 as OCS-BRIDGE provide rapid, easy-to-use alternatives to traditional pen-and-paper testing, yet little work has been done to demonstrate the validity of these tests in this population, or to assess their relative strengths and weaknesses when compared with traditional batteries. This paper presents early data from a cohort of 17 participants with diffuse glioma who underwent traditional and OCS-BRIDGE assessment, both before and after surgery, and at several follow-ups. The results show that both methods detected cognitive impairments in participants who did not primarily present with self-reported cognitive problems. Results revealed that, when compared with a 2–3-h traditional assessment, a 30-min OCS-BRIDGE assessment significantly detected fewer impairments in the areas of attention and memory. However, OCS-BRIDGE significantly detected more impairments in non-verbal skills. Memory and attention screening using only a few items cannot make the kind of fine distinctions possible with a longer test, and Fig. 3 A Cognitive deficits by domain from preoperative neuropsychological testing and OCS-BRIDGE assessments. B Comparison of digit span analysis between neuropsychological testing and OCS-BRIDGE. C Total preoperative deficits shown by neuropsychological testing and OCS-BRIDGE Table 2 Average ratio and standard deviation of cognitive deficits across patients for each domain and assessment. A positive T value indicates a higher ratio of deficits detected by traditional neuropsychology compared with OCS-BRIDGE Neuropsychology average ratio (SD) OCS-BRIDGE average ratio (SD) T value P value Attention Preoperative 0.255 (0.28) 0.025 (0.56) 3.35 0.002 Postoperative 0.262 (0.23) 0.036 (0.76) 2.64 0.016 Memory Preoperative 0.078 (0.10) 0 (0) 3.24 0.003 Postoperative 0.131 (0.14) 0.031 (0.09) 1.79 0.088 Non-verbal skills Preoperative 0 (0) 0.034 (0.04) − 3.11 0.004 Postoperative 0 (0) 0.080 (0.10) − 3.16 0.005 2027
Acta Neurochirurgica (2022) 164:2021–2034 1 3 Table 3 Raw, standard deviation (SD), and Z-scored performance of each item included in traditional neuropsychology and OCS-BRIDGE. T-values and P-values result from a paired t-tests comparing scores before (preop) and after (postop) surgery Item name Rawpreop (SD) Zpreop Rawpostop (SD) Zpostop t-value P-value OCS-BRIDGE Attention hearts.overallScore 29.31 (− 1.08) 0.34 28.63 (− 1.41) − 0.06 1.33 0.20 hearts.spaceAsymmetry − 0.002 (− 0.03) 0.03 0 (− 0.07) 0.10 − 0.19 0.85 hearts.objectAsymmetry 0.12 (− 0.6) 0.11 0.38 (− 0.74) 0.55 − 0.93 0.36 hearts.perseverativeResponsesTotal 0 (0) 0.06 0 (0) 0.06 0.00 1.00 hearts.organisationIndex − 2.64 (− 0.76) 0.16 − 2.13 (− 0.63) 0.70 − 1.64 0.11 salt.overallFlashScore 3.53 (− 0.72) − 0.02 3.43 (− 0.79) − 0.16 0.30 0.76 salt.numberAllTargetsDetected 35.71 (− 0.69) 0.18 35.29 (− 1.5) − 0.28 0.96 0.35 salt.RTCoefficient − 0.15 (− 0.06) 0.81 − 0.15 (− 0.03) 0.90 − 0.26 0.80 salt.targetBias 0 (− 0.02) − 0.06 0 (− 0.01) 0.22 − 0.66 0.52 salt.RTBias 0.01 (− 0.04) 0.17 0.04 (− 0.04) 0.68 − 1.21 0.24 Perception extinction.totalCorrect 17.94 (− 0.24) 0.12 17.43 (− 0.79) − 1.30 2.48 0.02 extinction.fieldProblem 0 (0) − 0.02 − 0.14 (− 0.38) − 0.61 1.61 0.12 extinction.leftExtinction 0 (0) − 0.07 0 (0) − 0.07 0.00 1.00 extinction.rightExtinction 0 (0) − 0.08 0.14 (− 0.9) 0.34 − 0.68 0.51 boat.lineHeight − 0.99 (− 0.23) − 0.78 − 1.26 (− 0.23) − 2.21 2.70 0.01 boat.meanDeviation − 0.56 (− 2.29) − 0.11 − 0.4 (− 1.4) − 0.05 − 0.18 0.86 pstl.overallScore 6 (0) 0.13 6 (0) 0.13 0.00 1.00 Memory memory.verbalFreeRecall 3.06 (− 0.97) − 0.18 3 (− 1.51) − 0.25 0.12 0.91 memory.verbalOverallRecall 3.88 (− 0.33) 0.02 3.75 (− 0.46) − 0.34 0.82 0.42 memory.episodicMemoryScore 4 (0) 0.18 4 (0) 0.18 0.00 1.00 orientation.overallScore 4 (0) 0.17 3.88 (− 0.35) − 0.61 1.49 0.15 fins.forwardDigitSpan 6.76 (− 0.9) − 0.20 6.14 (− 1.07) − 0.66 1.46 0.16 fins.backwardDigitSpan 4.82 (− 1.55) − 0.39 4.43 (− 1.4) − 0.65 0.58 0.57 pstp.prospectiveScore 4 (0) 0.71 4 (0) 0.71 0.00 1.00 pstp.retrospectiveScore 4 (0) 0.68 4 (0) 0.68 0.00 1.00 Language Naming.overallScore 4 (0) 0.32 4 (0) 0.32 0.00 1.00 semantics.overallScore 3 (0) 0.06 3 (0) 0.06 0.00 1.00 reading.overallScore 15 (0) 0.34 15 (0) 0.34 0.00 1.00 Praxis imitation.handScore 5.88 (− 0.49) 0.00 5.88 (− 0.35) − 0.02 0.04 0.97 imitation.fingerScore 6 (0) 0.20 6 (0) 0.20 0.00 1.00 imitation.overallScore 11.88 (− 0.49) 0.12 11.88 (− 0.35) 0.11 0.04 0.97 Number numerical.overallArithmeticScore 3.47 (− 0.94) − 0.87 3.63 (− 0.52) − 0.50 − 0.43 0.67 numerical.overallWritingScore 2.88 (− 0.49) − 1.00 2.88 (− 0.35) − 1.07 0.04 0.97 Neuropsychological Assessments Attention WAIS-IV.Digit.Span.Forward 9.88 (− 2.5) − 0.04 9.5 (− 2.24) − 0.17 0.44 0.66 WAIS-IV.Digit.Span.Backward 8.12 (− 2.2) − 0.63 7.21 (− 1.85) − 0.93 1.22 0.23 WAIS-IV.Digit.Symbol 66.29 (− 13.85) − 0.18 66.07 (− 15.43) − 0.19 0.04 0.97 Non-verbal skills BMIPB.Complex.Figure.copy 79.12 (− 1.17) 0.30 79.38 (− 0.87) 0.40 − 0.69 0.50 VOSP.Object.Decision 18.29 (− 1.16) − 0.19 19 (− 1.22) 0.25 − 1.61 0.12 VOSP.Number.Location 9.41 (− 0.87) 0.01 9.38 (− 0.65) − 0.01 0.09 0.93 VOSP.Cube.Analysis 9.76 (− 0.56) 0.39 9.77 (− 0.44) 0.39 − 0.02 0.98 2028
Acta Neurochirurgica (2022) 164:2021–2034 1 3 as a consequence can have a more conservative threshold for impairment. In contrast, OCS-BRIDGE measures with reaction time assessments can make very fine individual difference distinctions. The results suggest that a combined approach, using traditional assessment in those areas where brief screening, may be less sensitive, and OCS-BRIDGE style measures for reaction time and perceptual tasks may be most effective. Table 3 (continued) Item name Rawpreop (SD) Zpreop Rawpostop (SD) Zpostop t-value P-value Memory AMIPB.Story-Immediate.Recall 34.71 (− 8.99) 0.17 27 (− 9.04) − 0.59 2.37 0.02 AMIPB.Story-Delayed.Recall 32.82 (− 11.14) 0.18 27.54 (− 11.4) − 0.32 1.28 0.21 BMIPB.Word.List.A1-A15 54.59 (− 9.1) − 0.22 50.14 (− 9.36) − 0.84 1.34 0.19 BMIPB.Word.List.A6 12.82 (− 2.53) 0.29 10.5 (− 2.95) − 0.64 2.36 0.03 BMIPB.Word.List Word.Recognition 28.71 (− 0.99) 0.08 27.64 (− 2.47) − 0.74 1.63 0.11 BMIPB.Word.List List.Recognition 28.94 (− 1.56) − 0.04 27.5 (− 3.61) − 1.00 1.49 0.15 BMIPB.Complex.Figure Immediate.Recall 65.47 (− 7.8) 0.02 61.36 (− 13) − 0.39 1.09 0.28 BMIPB.Complex.Figure Delayed.Recall 63.24 (− 8.21) 0.11 59.57 (− 13.36) − 0.23 0.94 0.36 BMIPB.Design.Learning-A1-A15 37.35 (− 6.19) − 0.01 35.14 (− 7.22) − 0.38 0.92 0.37 BMIPB.Design.Learning-A6 8.29 (− 1.16) 0.07 8.14 (− 1.61) − 0.04 0.30 0.76 BMIPB.Design.Learning Recognition 39.41 (− 1.18) 0.32 38.43 (− 2.59) − 0.12 1.40 0.17 BMIPB.Design.Learning Identification 9.59 (− 1) 0.13 9 (− 1.62) − 0.27 1.24 0.22 Language Letter.Fluency 37.82 (− 14.55) − 0.25 30.71 (− 15.04) − 0.91 1.33 0.19 Semantic.Fluency 20.71 (− 5.92) 0.22 16.5 (− 5.68) − 0.79 2.00 0.05 Graded.Naming.Test 19.65 (− 3.87) − 0.66 19.57 (− 5) − 0.68 0.05 0.96 Syntactic.Speech.Comprehension 24.88 (− 0.93) − 0.08 24.57 (− 1.99) − 0.29 0.57 0.57 Executive functioning Hayling.Initiation.(time) − 3.88 (− 3.76) − 0.76 − 2.5 (− 1.61) − 0.13 − 1.28 0.21 Hayling.Inhibition.(time) − 21.24 (− 16.06) − 0.36 − 23 (− 21.01) − 0.49 0.27 0.79 Hayling.Inhibition.(score) 10.94 (− 3.23) − 0.04 10.86 (− 3.72) − 0.07 0.07 0.95 Brixton − 10.94 (− 4.49) 0.89 − 10.92 (− 7.1) 0.89 − 0.01 0.99 Fig. 4 Association between Z-scores derived from OCS-BRIDGE and neuropsychological testing. Plots for overlapping domains (Attention, Memory, and Non-verbal skills) and for the total average across domains (Total) 2029